Functional improvement of dystrophic muscle by myostatin blockade
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Mice and cattle with mutations in the myostatin (GDF8) gene show a marked increase in body weight and muscle mass, indicating that this new member of the TGF-beta superfamily is a negative regulator of skeletal muscle growth. Inhibition of the myostatin gene product is predicted to increase muscle mass and improve the disease phenotype in a variety of primary and secondary myopathies. We tested the ability of inhibition of myostatin in vivo to ameliorate the dystrophic phenotype in the mdx mouse model of Duchenne muscular dystrophy (DMD). Blockade of endogenous myostatin by using intraperitoneal injections of blocking antibodies for three months resulted in an increase in body weight, muscle mass, muscle size and absolute muscle strength in mdx mouse muscle along with a significant decrease in muscle degeneration and concentrations of serum creatine kinase. The functional improvement of dystrophic muscle by myostatin blockade provides a novel, pharmacological strategy for treatment of diseases associated with muscle wasting such as DMD, and circumvents the major problems associated with conventional gene therapy in these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The interest in myostatin was generated by recent studies where antibodies for myostatin were created and administered to adult rodents, which resulted in an increase in body mass, muscle mass, muscle size, and strength [11,12].”
From Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males (2006) · cites this paper as [12]
Citations
Cites
Textbook of Medical Physiology
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1363_2 · Cited by 9,749
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
TEXTBOOK OF MEDICAL PHYSIOLOGY
GUYTON, A. C. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196701000-00031 · Cited by 2,837
Dystrophin expression in the mdx mouse restored by stem cell transplantation
Gussoni, E., Soneoka, Y., Strickland, C. D., Buzney, E. A., Khan, M. K., Flint, A. F., Kunkel, L. M., & Mulligan, R. C. (1999) · Nature · doi:10.1038/43919 · Cited by 1,802 · cited 1×
“In comparison with conventional transgenic, cell and gene therapy approache”
BackgroundX chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 1×
“Alterations in Smad 2 and 3 phosphorylation would be predicted to regulate the formation of Smad complexes, their nuclear translocation and transcriptional regulation of genes associated with commitment of muscle progenitor”
BackgroundA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Dystrophin protects the sarcolemma from stresses developed during muscle contraction
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3710 · Cited by 1,526 · cited 1×
“The regimen did not completely reverse dystrophic changes; physiological parameters evaluated by ex vivo tests, such as susceptibility to damage by lengthening contraction”
BackgroundAhima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Self-citation
Research works printed but not linked: 2
- Jalenak, M. et al. Transcriptional changes arising from in vivo inhibition of myostatin. J. Neurol. Sci. 199 (suppl)., S83 (2002)
- Engel, A. G. & Franzini-Armstrong, C. Myology (McGraw-Hill, New York, 1994)
Cited by
Items 701–800 of 853
Khamoui, A. V., Abraham, A., Pórszász, J., Kovanecz, I., Constantinescu, S., Rossiter, H. B., & Reisz‐Porszasz, S. (2026) · Experimental Physiology · doi:10.1113/ep093775 · Cited by 1
Epis, R., Rovetta, G., Ferrari, G., Bonfanti, C., Careccia, G., & Messina, G. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70333 · Cited by 1
“Mstn inhibition through different strategies (monoclonal antibodies, modified follistatin, Mstn inhibitory prodomain) resulted to be beneficial in mdx mice [67–69].”
Weiner, G. (2009) · Eukaryon · Cited by 1
Maaeni, Y. M. A., Lee, S. B., Choi, D. H., Mozdziak, P. E., & Kim, Y. (2017) · International Journal of Poultry Science · doi:10.3923/ijps.2018.8.21 · Cited by 1
Role of Myostatin in Skeletal Muscle Growth and Development: Implications for Sarcopenia
McFarlane, C., Sharma, M., & Kambadur, R. (2010) · Springer eBooks · doi:10.1007/978-90-481-9713-2_18 · Cited by 2
Zebrafish Assays for Identifying Potential Muscular Dystrophy Drug Candidates
Tang, J., Tang, S., Haldi, M., & Seng, W. L. (2011) · Wiley eBooks · doi:10.1002/9781118102138.ch18 · Cited by 1
Energy Metabolism in Skeletal Muscle and its Link to Insulin Resistance
Wang, M. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch6 · Cited by 1
Small interfering RNA targeting the human myostatin gene
Furalyov, V. A., Кравченко, И. В., & Popov, V. O. (2009) · Molecular Biology · doi:10.1134/s0026893309040098 · Cited by 1
Myostatin as a Potential Therapeutic Target for Obesity and Insulin Resistance
Jeong, K., & Choi, C. S. (2011) · The Korean Journal of Obesity · doi:10.7570/kjo.2011.20.3.91 · Cited by 1
Testosterone Booster Recommendation Report
LeBaron, T. W. (2011) · Cited by 1
Skeletal Muscle Dysfunction and Pulmonary Rehabilitation in COPD
Kon, S. S. C., & Man, W. D. (2012) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0b013e31825d59fe · Cited by 1
“Neutralizing antibodies to myostatin have enabled increases in muscle mass and improved muscle strength in animal models.(83,84) PPAR-d agonists have recently been shown to mimic and enhance exercise training, and AICAR, an AMP-kinase agonist, was sufficient to improve exercise endurance in mice alone.”
BackgroundBachtarzi, H., & Farries, T. (2016) · InTech eBooks · doi:10.5772/62282 · Cited by 1
“These observations were recently translated into thera‐ peutic interventions, whereby inhibiting the MSTN signalling pathway using pharmacological agents has shown real benefits in DMD but also in other muscle wasting pathologies such as sarcopenia and cancer cachexia [41–45].”
BackgroundMuscle: Anatomy, Physiology, and Biochemistry
Dantzig, J. A., Pacheco-Pinedo, E. C., & Goldman, Y. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10005-1 · Cited by 2
Ohsawa, Y., Nishimatsu, S., Fujino, M., & Sunada, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-55678-7_5 · Cited by 1
Duchenne And Becker Muscular Dystrophies
Kunkel, L. M., & Steffen, L. S. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch7 · Cited by 1
Genetic and Cell-Mediated Therapies for Duchenne Muscular Dystrophy
Baglieri, J., & Bertoni, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00010-5 · Cited by 1
Zaburzenia kaskady transformujących czynnikow wzrostu typu β w wybranych patologiach człowieka
Zakrzewski, P. (2012) · Cited by 1
Inactivation of myostatin by photooxygenation using functionalized d -peptides
Okamoto, H., Murano, S.-A., Ikekawa, K., Katsuyama, M., Konno, S., Taguchi, A., Takayama, K., Taniguchi, A., & Hayashi, Y. (2023) · RSC Medicinal Chemistry · doi:10.1039/d2md00425a · Cited by 1
Molecular Pathogenesis of Skeletal Muscle Abnormalities in Marfan Syndrome
Cohn, R. D., & Dietz, H. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00071-5 · Cited by 1
Kumar, N. B. (2012) · Springer eBooks · doi:10.1007/978-3-642-27233-2_4 · Cited by 1
Béchir, N., Pecchi, É., Vilmen, C., Bernard, M., Bendahan, D., & Giannesini, B. (2018) · Muscle & Nerve · doi:10.1002/mus.26306 · Cited by 1
Barthélémy, I. (2010) · theses.fr (ABES) · doi:10.70675/b8b689c3z8c8bz4303z98fdz158787da1ba7 · Cited by 1
Genes that affect meat production, fat deposition and carcass weight in pigs
Kunhareang, S. (2014) · Lincoln University Research Archive (Lincoln University) · Cited by 1
dos Santos, A. L. F. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2012.tde-05022013-092744 · Cited by 2
Lu, W.-F., Zhao, J. Z., Wei, G., & Shan, X. (2007) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.2007.827 · Cited by 1
Prednisone in dystrophin-deficient Caernorabditis elegans
Luca, A. D. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.06.006 · Cited by 1
The role of myostatin during postnatal myogenesis and sarcopenia
Siriett, V. (2007) · Research Commons (University of Waikato) · Cited by 1
Han, J. (2012) · Lincoln University Research Archive (Lincoln University) · Cited by 1
The effects of Akt overexpression in normal and dystrophic skeletal muscle
Blaauw, B. (2007) · Padua Research Archive (University of Padova) · Cited by 1
Animal Models for Muscular Disorders
Wells, D. J. (2004) · CRC Press eBooks · doi:10.1201/9781420039627.ch10 · Cited by 1
Tools to enable animal to human translation: Assessing the value of disease models
Ferreira, G. S. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/157 · Cited by 2
Il doping genetico: ipotesi surreale o inquietante realtà?
Giganti, M., Minella, D., Testa, B., & Novelli, G. (2010) · Cineca Institutional Research Information System (Tor Vergata University)
Baán, J. A. (2015) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2587
Patho-genetic characterization of the muscular dystrophy gene myotilin
Garvey, S. M. (2007) · DukeSpace (Duke University)
Combinatorial Gene Therapy Strategies for Treating Muscular Dystrophies
Winbanks, C. E., & Gregorevic, P. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1207-7_8
“Efforts to therapeutically inhibit myostatin have stimulated the development of soluble myostatin receptors, dominant-negative dimerizing propeptides, endogenous and artificial binding proteins, and blocking antibodies (Zhu et al. 2000; Lee and McPherron 2001; Bogdanovich et al. 2002; Whittemore et al. 2003; Lee et al…”
BackgroundLes copolymères à blocs pour le transfert de gènes dans le muscle squelettique
Richard, P. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Estudo da expressão da miostatina em modelos murinos para doenças neuromusculares.
Zilbersztajn, D. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.87.2011.tde-14092011-140119 · Cited by 2
Epigenetic reprogramming of somatic cells by nuclear transplant in zebrafish
Pérez-Camps, M. (2009) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/6902
Embryonic temperature and the genes regulating myogenesis in teleosts
Macqueen, D. J. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Bookless, C. (2006) · University of Southern Queensland research data collection · doi:10.26192/9y814
Santos, A. D. R. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.39.2013.tde-27032013-093640
Taheri‐Ghahfarokhi, A., Tahmoorespur, M., Dehghani, H., Shamshirgaran, Y., Sümer, H., Liu, J., & Verma, P. J. (2014) · The Indian Journal of Animal Sciences · doi:10.56093/ijans.v84i11.44725
The principles of molecular therapies for muscle diseases
Karpati, G., & Gilbert, R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.013 · Cited by 1
The Effect of a Myostatin Antagonist on the Healing of Burn Wounds in Skin.
Fieten, D. J. (2009) · Research Commons (University of Waikato)
Metabonomic study of the biochemical profiles of heterozygous myostatin knockout swine
XU, D. P. J., Dengke, P. A. N., Jie, Z. H. A. O., Jianwu, W. A. N. G., Xiaohong, H. E., Yuehui, M. A., & Ning, L. I. (2015) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2015045
Improving gene transfer into skeletal muscle through genetic retargeting of adenoviral vectors
Thirion, C. (2004) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.6339
The Regulation of Satellite Cell Function in Skeletal Muscle Regeneration and Plasticity
Gillespie, M. A. K., Holterman, C. E., & Rudnicki, M. A. (2007) · Springer eBooks · doi:10.1007/1-4020-5177-8_6
“Their muscles are also less degenerated, resulting in lower serum creatine kinase concentrations (Bogdanovich et al., 2002).”
BackgroundHulmi, J. J. (2009) · Jyväskylä University Digital Archive (University of Jyväskylä) · Cited by 1
Anti-myostatin antibody therapy for myopathies
Sunada, Y. (2011) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.51.1157
Regulation of the Structure and Function of Skeletal Muscle and Tendon by Myostatin.
Mendias, C. L. (2007) · Deep Blue (University of Michigan) · Cited by 2
Fulmer, T. (2008) · Science-Business eXchange · doi:10.1038/scibx.2008.226
Gene therapy for Duchenne muscular dystrophy
Suzuki, N., Miyagoe‐Suzuki, Y., & Takeda, S. (2006) · Future Neurology · doi:10.2217/14796708.2.1.87
“Myostatin blockade in mdx mice results in increases in both muscle mass and muscle strength and reductions in muscle fiber degeneration and serum creatine kinase levels [61].”
BackgroundYu, C.-Y., Wang, B., Wang, Z., Cao, Z., Li, J., & Xiao, X. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.08.556
Myostatin as a regulator of fiber size
Solecki, M. (2010) · Spectrum Research Repository (Concordia University)
Characterization of SMAD3 function in skeletal muscle growth
Ge, X. (2012) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/48683
attenuates disuse muscle atrophy and weakness in Acute antibody-directed myostatin inhibition
Lynch, S. E., Murphy, K. T., Ryall, J. G., Ibebunjo, C., Judge, A. R., Beharry, A. W., Sandesara, P. B., Roberts, B. M., Ferreira, L. F., Sarah, M., et al. (2015)
Physiology & Biochemistry/Review Article
Haisma, H. J., & de Hon, O. M. (2006)
Rocha, J. L., & Pires, M. M. (2010)
Exercise mitigates the effects of hyperhomocysteinemia on adverse skeletal muscle remodeling.
Winchester, L. J. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2224
“12 producing elevated muscle weight, contractile force and cross sectional area, as well as attenuating macrophage infiltration into the skeletal muscle (Bogdanovich et al., 2002; Nakatani et al., 2008).”
BackgroundInfluentialResveratrol as a Novel Therapeutic Agent for Treating Duchenne Muscular Dystrophy
Burt, M. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-3321
Hentilä, J. (2015) · Jyväskylä University Digital Archive (University of Jyväskylä)
Major Processes for Muscle Gain and Loss
(2010) · CRC Press eBooks · doi:10.1201/ebk1439813621-c5
Skeletal muscle atrophy: the role of miRNAs; Atrofia do músculo esquelético: a função dos miRNAs
Soares, R. (2012) · Cited by 1
Frommer, S. A. (2008) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Fiol, C., & Calbet, J. A. L. (2003)
Miostatina e redução da massa muscular em doenças crônicas
Filho, J. D. M. (2009)
Khurana, T. S., Pistilli, E. E., Bogdanovich, S., Mosqueira, M., Lachey, J. L., Kunkel, L. M., Wagner, K. R., Rahimov, F., King, O. D., Warsing, L. C., et al. (2011)
Self-citationChandrashekar, P. (2016) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/67320
McKay, B. R., & Parise, G. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1232-8_10
Skeletal Muscle Atrophy and Hypertrophy
Glass, D. J. (2005) · CRC Press eBooks · doi:10.1201/9780849333798.ch3
Visions & Reflections (Minireview) Myostatin as a therapeutic target for musculoskeletal disease
Bradley, L. A., Yaworsky, P. J., & Walsh, F. S. (2008)
2. Molecular Mechanisms and Therapeutic Strategies for Muscular Dystrophies
Toda, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.1578
The regulation of cancer cachexia and colorectal carcinogenesis by myostatin
Wijesoma, I. W. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72527
Wachstumsfaktoren unter besonderer Berücksichtigung des muskuloskelettalen Systems
Bachl, N., Lorenz, C. D., & Goldspink, G. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1591-6_8 · Cited by 2
Gennari, A. (2013) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/gennari-arianna_phd2013-01-11
Glycogen distribution and metabolic alterations in the hypermuscular, myostatin mutant compact mice
Kocsis, T. (2017) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.4124
Impacts of Bmp6 on Myogenic Cell Proliferation, Differentiation, and Satellite Cell Population
Sun, W. (2010) · University of Florida Digital Collections (University of Florida)
Body building best without myostatin
Brazil, M. I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd995
A Boy with Large Muscles, Leg Pain, and Elevated Serum Creatine Kinase
Bertorini, T. E. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7332-7.50083-0
Carlos, J. P. C. (2014) · Buleria (Universidad de León) · doi:10.18002/10612/3602 · Cited by 1
Muscle Stem Cell Biology and Implications in Gene Therapy
Partridge, T. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-03095-7_4
Minderis, P., Libnickienė, I., & Ratkevičius, A. (2016) · Baltic Journal of Sport and Health Sciences · doi:10.33607/bjshs.v2i101.56
“Indeed, myostatin targeting by antibodies ameliorated muscle wasting in mdx mice which serve as a model for Duchenne muscle dystrophy (Bogdanovich et al., 2002; Wagner, McPherron, Winik, & Lee, 2002).”
BackgroundMAMMALIAN MSS51 IS A NEWLY DESCRIBED, SKELETAL MUSCLE-SPECIFIC GENE
Moyer, A. L. (2015)
Recent Development of Therapy for Muscular Dystrophy
Toda, T. (2014) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.103.2820
Medicinal Chemistry of Mid-sized Molecules on Biologically Active Peptides
Takayama, K., & Hayashi, Y. (2015) · Journal of Synthetic Organic Chemistry Japan · doi:10.5059/yukigoseikyokaishi.73.737
Role of trophic factors in development and regeneration of skeletal muscles
Ciecierska, A., Sadkowski, T., & Motyl, T. (2019) · Medycyna Weterynaryjna · doi:10.21521/mw.6348
“Ponadto, u myszy z dystrofią mięśniową zablokowanie miostatyny wyżej wspomnianymi przeciwciałami zapobiegało wystąpieniu objawów chorobowych (7).”
Myostatin Expression in the Heart is Temporally and Regionally Distinct
Savinova, I. (2021) · The Atrium (University of Guelph)
Hoffman, D. B. (2020) · University of Minnesota Digital Conservancy (University of Minnesota)
Roles of autophagy & mitophagy in the regulation of skeletal muscle function
Leduc‐Gaudet, J. (2021) · eScholarship@McGill (McGill) · doi:10.82308/1594
Muscular Dystrophies Affecting the Heart
Caskey, C. T. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_125
Treatment and Management of Muscular Dystrophies
Rocha, C. T., & Escolar, D. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-71317-7.00020-2
Growth Factors Do Not Improve Muscle Function in Young or Adult mdx Mice
Nielsen, T. L., Hornsyld, T. M., Pinós, T., Brolin, C., Vissing, J., & Krag, T. O. B. (2022) · Biomedicines · doi:10.3390/biomedicines10020304
“Sample size of each group was based on cohort sizes previously used [16].”
BackgroundMethodSelf-citationReggiani, C. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1089613.544880
Sahenk, Z., & Rodino‐Klapac, L. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6567-6_56
Myostatin Expression in MDS Patients with Wasting Syndrome
Garlemou, K., Alexandrak, M., Karras, G., Kyriakou, D. S., & Kourelis, T. V. (2022) · Asian Journal of Biological Sciences · doi:10.3923/ajbs.2022.1.8
Almeida, F. E. D. (2009) · Revista Brasileira de Fisiologia do Exercício · doi:10.33233/rbfe.v8i4.3597
Skeletal Muscle Atrophy and Hypertrophy
Glass, D. J. (2005) · CRC Press eBooks · doi:10.1201/9781420048957.ch3
Metadata
- Authors
- Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S.
- Affiliations
- University of Pennsylvania (US)
- Pfizer (United States) (US)
- Corresponding author
- Khurana, Tejvir S.
- Venue
- Nature
- Published
- 2002-11
- Volume
- 420
- Issue
- 6914
- Pages
- 418-421
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083700023
- Semantic Scholar
- 590fb54cd1f2d89d44f4e1ad999be802dc756277
- Cited by
- 831
- References
- 31
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 19 · 2023: 15 · 2022: 21 · 2021: 20 · 2020: 23 · 2019: 32 · 2018: 23 · 2017: 34 · 2016: 28 · 2015: 43 · 2014: 34 · 2013: 38 · 2012: 48
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- myostatin, Duchenne muscular dystrophy, mdx mice, muscle atrophy, blocking antibodies, muscle mass, muscle strength, muscle degeneration, creatine kinase, TGF-beta superfamily, skeletal muscle growth
- MeSH terms
- Animals, Antibodies, Body Weight, Creatine Kinase, Male, Muscular Dystrophy, Animal, Organ Size, Transforming Growth Factor beta, Mice, Inbred mdx, Muscle, Skeletal, Muscle Fibers, Skeletal, Muscular Dystrophy, Duchenne, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.